Target intelligence / Profile preview

High mobility group nucleosomal binding domain 2 pseudogene 23 (HMGN2P23)

Target: HMGN2P23
Molecular classification: Pseudogene, long non-coding RNA (lncRNA, if transcribed)

Overview

HMGN2P23 is a human pseudogene with high sequence similarity to the high mobility group nucleosomal binding domain 2 (HMGN2) gene. Pseudogenes like HMGN2P23 are generally inactive in terms of protein production due to genetic mutations such as frameshifts, premature stop codons, or loss of regulatory/promoter sequences. While most pseudogenes do not have direct biological function, some are transcribed and may participate in regulation of gene expression via RNA-based mechanisms such as acting as miRNA decoys, producing noncoding RNAs, or affecting mRNA stability. There is no evidence that HMGN2P23 produces a protein, acts as a therapeutic target, or interacts directly with drugs. Its role, if any, in biology or disease is limited and currently undocumented[1][2][5][3].

Other names: HMGN2P23

Biological functions

Genomic relic: Marker of evolutionary historyPotential noncoding function: May generate noncoding RNAs (e.g., interfering, antisense, or regulatory RNAs)Gene expression regulation: Rarely, some pseudogenes regulate their parental genes through RNA, but no evidence specific to HMGN2P23

Disease associations

Other (Pseudogene deregulation is observed in some cancers and diseases, usually through indirect regulatory effects; no disease role documented for HMGN2P23)

Beyond the preview

Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 23 (HMGN2P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 23 (HMGN2P23).

Explore the full profile